Choice A reason: Topical analgesics relieve pain but do not address psoriasis’s underlying inflammation or scaling. Psoriasis involves immune-mediated epidermal hyperproliferation, causing scaly, burning plaques. Analgesics may reduce discomfort temporarily but fail to target the inflammatory process driven by T-cell activation, making this choice ineffective for managing psoriasis symptoms. Choice B reason: Colloidal oatmeal-based lotion soothes irritated skin but is insufficient for psoriasis, which requires anti-inflammatory treatment. Oatmeal reduces itching in conditions like eczema but does not address psoriasis’s silvery scales or immune-driven inflammation, making it an inadequate choice for controlling the client’s burning, bleeding plaques. Choice C reason: Topical antifungals treat fungal infections, not psoriasis, which is an autoimmune condition with no fungal etiology. The silvery, scaly plaques result from rapid keratinocyte turnover, not fungal growth, so antifungals are irrelevant, failing to reduce inflammation or scaling in this chronic inflammatory dermatologic condition. Choice D reason: Topical corticosteroids are effective for psoriasis, reducing inflammation, scaling, and burning by suppressing T-cell activity and cytokine production. They slow epidermal proliferation, alleviating silvery plaques and bleeding. Potent corticosteroids are standard for elbow and palm lesions, making this the appropriate prescription to teach the client for symptom control.